Systematic review of stroke thrombolysis service configuration

References

• Sandercock P, Berge E, Dennis M et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol. Assess.6(26), 1–112 (2002).
   PubMedGoogle Scholar
• Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Arch. Neurol.61, 1066–1070 (2004).
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev.3, CD000213 (2003).
   Google Scholar
• De Keyser J, Gdovinova Z, Uyttenboogaart M et al. Intravenous alteplase for stroke. Beyond the guidelines and in particular clinical situations. Stroke38, 2612–2618 (2007).
   PubMed Web of Science ®Google Scholar
• Schwamm LE, Pancioli A, Acker JE et al. Recommendations for the establishment of stroke systems of care. Recommendations from the American Stroke Association’s task force on the development of stroke systems. Stroke36, 690–703 (2005).
   PubMed Web of Science ®Google Scholar
• Acker JE, Pancioli A, Crocco TJ et al. Implementation strategies for emergency medical services within stroke systems of care. A policy statement from the American Heart Association/American Stroke Association expert panel on emergency medical services systems and the Stroke Council. Stroke116, 3097–3115 (2007).
   Google Scholar
• Wahlgren N, Ahmed N, Dávalos A et al.; for the SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke–Monitoring Study (SITS-MOST): an observational study. Lancet369, 275–282 (2007).
   PubMed Web of Science ®Google Scholar
• Yu RF, San Jose MC, Manzanilla BM et al. Sources and reasons for delays in the care of acute stroke patients. J. Neurol. Sci.199(1), 49–54 (2002).
   PubMed Web of Science ®Google Scholar
• Hess DC, Wang S, Gross H et al. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol.5, 275–278 (2006).
   PubMed Web of Science ®Google Scholar
• Audebert H. Telestroke: effective networking. Lancet Neurol.5, 279–282 (2006).
   PubMed Web of Science ®Google Scholar
• NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D et al. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke36(7), 1512–1518 (2005).
   PubMed Web of Science ®Google Scholar
• Chiu D, Krieger D, Villar-Cordova C et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke29(1), 18–22 (1998).
   PubMed Web of Science ®Google Scholar
• Sattin JA, Olson SE, Liu L et al. An expedited code stroke protocol is feasible and safe. Stroke37(12), 2935–2939 (2006).
   PubMedGoogle Scholar
• Silverman IE, Beland DK, Chhabra J et al. The ‘drip-and-ship’ approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn. Med.69(10), 613–620 (2005).
   PubMedGoogle Scholar
• Riopelle RJ, Howse DC, Bolton C et al. Regional access to acute ischemic stroke intervention. Stroke32(3), 652–655 (2001).
   PubMed Web of Science ®Google Scholar
• Steiner MM, Brainin M. The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur. J. Neurol.10(4), 353–360 (2003).
   PubMedGoogle Scholar
• Barber PA, Zhang J, Demchuk AM et al. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology56(8), 1015–1020 (2001).
   PubMed Web of Science ®Google Scholar
• Audebert HJ, Kukla C, Vatankhah B et al. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke37(7), 1822–1827 (2006).
   PubMed Web of Science ®Google Scholar
• Hess DC, Wang S, Hamilton W et al. REACH: clinical feasibility of a rural telestroke network. Stroke36(9), 2018–2020 (2005).
   PubMed Web of Science ®Google Scholar
• Rymer MM, Thurtchley D, Summers D et al. Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions. Stroke34(6), e58–e60 (2003).
   PubMedGoogle Scholar
• The Paul Coverdell Prototype Registries Writing Group. Acute Stroke Care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke36, 1232–1240 (2005).
   PubMed Web of Science ®Google Scholar
• Albers GW, Bates VE, Clark WM. Intravenous tissue-type plasminogen activator for treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA283(9), 1145–1150 (2000).
   PubMed Web of Science ®Google Scholar
• The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet363, 768–774 (2004).
   PubMed Web of Science ®Google Scholar
• Kothari R, Jauch E, Broderick J et al. Acute stroke: delays to presentation and emergency department evaluation. Ann. Emerg. Med.33(1), 3–8 (1999).
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke, Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. [NIH publication number: 97–4239]. Marler JR, Winters-Jones P, Emr M (Eds). National Institutes of Health, Bethesda, MD, USA 157–158 (1997).
   Google Scholar
• Nam HS, Han SW, Ahn SH et al. Improved time intervals by implementation of computerized physician order entry-based stroke team approach. Cerebrovasc. Dis.23(4), 289–293 (2007).
   PubMedGoogle Scholar
• Kwan J, Hand P, Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM97(5), 273–279 (2004).
   PubMed Web of Science ®Google Scholar
• Kwan J, Sandercock P. In-hospital care pathways for stroke. Cochrane Database Syst. Rev.4, AB002924 (2004).
   Google Scholar
• Ferri M, Sacchetti ML, De Luca A et al. Pre-hospital emergency pathways for people with suspected stroke. (Protocol) Cochrane Database Syst. Rev.1, CD005611 (2006).
   Google Scholar
• Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke36, 2500–2503 (2005).
   PubMed Web of Science ®Google Scholar
• Yip TR, Demaerschalk BM. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke38, 1952–1955 (2007).
   PubMed Web of Science ®Google Scholar
• Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev.4, CD000197 (2007).
   PubMedGoogle Scholar
• Szoeke CEI, Parsons MW, Butcher KS et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med. J. Aust.178(7), 324–328 (2003).
   PubMedGoogle Scholar
• Fink J. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment. NZ Med. J.118(1214), U1430 (2005).
   PubMedGoogle Scholar
• Batmanian JJ, Lam M, Matthews C et al. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department. Med. J. Aust.187(10), 567–570 (2007).
   PubMedGoogle Scholar
• Schwammenthal Y, Drescher MJ, Merzeliak O et al. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr. Med. Assoc. J.6(2), 70–74 (2004).
   PubMedGoogle Scholar
• Knoll T, Wimmer MLJ, Muller N et al. Systemic thrombolysis for acute ischemic stroke in clinical practice. Acta Clin. Croat. Supplement 37(1), 62–67 (1998).
   Google Scholar
• Muller N, Glahn J, Baumann T et al. Intensive care stroke units in two German hospitals. Acta Clin. Croat.37(2 Suppl.), 43–47 (1998).
   Google Scholar
• Wiegand N, Luthy R, Vogel B et al. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit. Swiss Med. Wkly134(1–2), 14–17 (2004).
   PubMedGoogle Scholar
• Cocho D, Belvis R, Marti-Fabregas J et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology64(4), 719–720 (2005).
   PubMed Web of Science ®Google Scholar
• Masjuan Vallejo J, onso de Lecinana Cases M, Garcia-Barragan N et al. [Thrombolytic treatment in acute ischemic stroke in a center without previous experience. Development of internal organization and first results]. Rev. Clin. Esp.206(10), 485–490 (2006).
   PubMedGoogle Scholar
• Barroso B, Larrieu JM, Morisset C et al. [Feasibility of stroke thrombolysis at Pau Hospital, France]. Presse Med.36(6 Pt 1), 859–866 (2007).
   PubMedGoogle Scholar
• Garcia-Monco JC, Pinedo A, Escalza I et al. Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients. Clin. Neurol. Neurosurg.109(1), 50–53 (2007).
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Skowronska M, Litwin T et al. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated. Emerg. Med. J.24(2), 96–99 (2007).
   PubMedGoogle Scholar
• Garcia-Garcia J, Gracia-Gil J, Sopelana-Garay D et al. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete]. Rev. Neurol.46(1), 7–12 (2008).
   PubMedGoogle Scholar
• Smith RW, Scott PA, Grant RJ et al. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. Acad. Emerg. Med.6(6), 618–625 (1999).
   PubMedGoogle Scholar
• Akins PT, Delemos C, Wenthworth D et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology55(12), 1801–1805 (2000).
   PubMed Web of Science ®Google Scholar
• Katzan IL, Furlan AJ, Lloyd LE et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA283(9), 1151–1158 (2000).
   PubMed Web of Science ®Google Scholar
• Burgin WS, Staub L, Chan W et al. Acute stroke care in non-urban emergency departments. Neurology57(11), 2006–2012 (2005).
   Google Scholar
• Goldstein LB, Edwards MG, Wood DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology20(3), 196–200 (2001).
   PubMedGoogle Scholar
• Morgenstern LB, Bartholomew LK, Grotta JC et al. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch. Intern. Med.163(18), 2198–2202 (2003).
   PubMedGoogle Scholar
• Jahnke HK, Zadrozny D, Garrity T et al. Stroke teams and acute stroke pathways: one emergency department’s two-year experience. J. Emerg. Nurs.29(2), 133–139 (2003).
   PubMedGoogle Scholar
• Katzan IL, Graber TM, Furlan AJ et al. Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets. Stroke34(4), 994–998 (2003).
   PubMed Web of Science ®Google Scholar
• Douglas VC, Tong DC, Gillum LA et al. Do the Brain Attack Coalition’s criteria for stroke centers improve care for ischemic stroke? Neurology64(3), 422–427 (2005).
   PubMed Web of Science ®Google Scholar
• Kahn JH, Viereck J, Kase C et al. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke. J. Emerg. Med.29(3), 273–277 (2005).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Kirmani JF, Sayed MA et al. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology64(12), 2115–2120 (2005).
   PubMed Web of Science ®Google Scholar
• Deng YZ, Reeves MJ, Jacobs BS et al. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology66(3), 306–312 (2006).
   PubMed Web of Science ®Google Scholar
• Hills NK, Johnston SC. Why are eligible thrombolysis candidates left untreated? Am. J. Prev. Med.31(6 Suppl. 2), S210–S216 (2006).
   PubMed Web of Science ®Google Scholar
• Majersik JJ, Smith MA, Zahuranec DB et al. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke38(12), 3213–3217 (2007).
   PubMed Web of Science ®Google Scholar
• Owe JF, Sanaker PS, Naess H et al. The yield of expanding the therapeutic time window for tPA. Acta Neurol. Scand.114(5), 354–357 (2006).
   PubMed Web of Science ®Google Scholar
• Sobesky J, Frackowiak M, Zaro Weber O et al. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis. Cerebrovasc. Dis.24(1), 56–65 (2007).
   PubMed Web of Science ®Google Scholar
• Mehdiratta M, Woolfenden AR, Chapman KM et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can. J. Neurol. Sci.33(2), 214–216 (2006).
   PubMedGoogle Scholar
• Yoneda Y, Mori E, Uehara T et al. Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital. Eur. J. Neurol.8(5), 483–488 (2001).
   PubMedGoogle Scholar
• Debiais S, Bonnaud I, Giraudeau B et al. [Creation of a regional stroke network in Tours hospital (France): consequences for stroke care and thrombolysis]. Rev. Neurol.163(8–9), 817–822 (2007).
   PubMedGoogle Scholar
• Tardy J, Albucher JF, Pariente J et al. [Intravenous rt-PA for acute ischemic stroke: 69 consecutive patients managed in an emergency stroke centre]. Rev. Neurol.163(3), 349–357 (2007).
   PubMedGoogle Scholar
• Merino JG, Silver B, Wong E et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke33(1), 141–146 (2002).
   PubMed Web of Science ®Google Scholar
• Lattimore SU, Chalela J, Davis L et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke34(6), e55–e57 (2003).
   PubMed Web of Science ®Google Scholar
• Weir NU, Buchan AM. A study of the workload and effectiveness of a comprehensive acute stroke service. J. Neurol. Neurosurg. Psych.76(6), 863–865 (2005).
   PubMed Web of Science ®Google Scholar
• Schwab S, Vatankhah B, Kukla C et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology69(9), 898–903 (2007).
   PubMed Web of Science ®Google Scholar
• LaMonte MP, Bahouth MN, Hu P et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke34(3), 725–728 (2003).
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Rosenthal ES, Hirshberg A et al. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad. Emerg. Med.11(11), 1193–1197 (2004).
   PubMed Web of Science ®Google Scholar
• Wang DZ, Rose JA, Honings DS et al. Treating acute stroke patients with intravenous tPA: the OSF Stroke Network experience. Stroke31(1), 77–81 (2000).
   PubMed Web of Science ®Google Scholar
• Asimos AW, Norton HJ, Price MF et al. Therapeutic yield and outcomes of a community academic hospital code stroke protocol. Acad. Emerg. Med.11(4), 361–370 (2004).
   PubMed Web of Science ®Google Scholar
• Frey JL, Jahnke HK, Goslar PW et al. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology64(1), 154–156 (2005).
   PubMed Web of Science ®Google Scholar
• Rymer MM, Thrutchley DE. Organizing regional networks to increase acute stroke intervention. Neurol. Res.27(Suppl. 1), S9–S16 (2005).
   PubMed Web of Science ®Google Scholar